Lipid Abnormalities and Association with Atopic Allergic Diseases
US-2024159778-A1 · May 16, 2024 · US
US12306194B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12306194-B2 |
| Application number | US-202017440413-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 18, 2020 |
| Priority date | Mar 19, 2019 |
| Publication date | May 20, 2025 |
| Grant date | May 20, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention aims to provide a fluorescent reagent capable of highly sensitive imaging of a lipid droplet at a level ranging from cultured cells to individuals. A lipid droplet detection reagent including a compound represented by the following General Formula (I) is provided. In the formula, m represents an integer of 0 to 5; n represents an integer of 0 to 5; X is selected from the group consisting of a sulfur atom, an oxygen atom, and a group represented by NR; R is a hydrogen atom or a group represented by —(CH 2 ) y CH 3 ; and y represents an integer of 0 to 5.
Opening claim text (preview).
The invention claimed is: 1. A lipid droplet detection method comprising the step of: administering to a biological sample or a biological individual, a compound of Formula (I): wherein m represents an integer of 0 to 5; n represents an integer of 0 to 5; X is selected from the group consisting of a sulfur atom, an oxygen atom, and a group represented by NR; R is a hydrogen atom or a group represented by —(CH 2 ) y CH 3 ; and y represents an integer of 0 to 5; and detecting a fluorescence signal of the compound to detect the lipid droplet. 2. The detection method according to claim 1 , wherein m and n are 1. 3. The detection method according to claim 1 , wherein y is 0. 4. The detection method according to claim 1 , for detection of a lipid droplet(s) in a biological sample. 5. The detection method according to claim 4 , wherein the biological sample is a cell or a tissue. 6. The detection method according to claim 1 , for detection of a lipid droplet(s) in a biological individual. 7. The detection method according to claim 1 , wherein a solution containing: the compound; and a solubilizer; is administered to a biological sample or a biological individual. 8. The detection method according to claim 7 , wherein the solubilizer is albumin. 9. A compound of Formula (I)′: wherein m represents an integer of 0 to 5; n represents an integer of 0 to 5; X′ is an oxygen atom. 10. The compound according to claim 9 , wherein m and n are 1.
with indicators, stains, dyes, tags, labels, marks · CPC title
Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title
Coumarine dyes · CPC title
involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.